Variant report
Variant | esv2619200 |
---|---|
Chromosome Location | chr5:61292891-61294521 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs373513230 | chr5:61293049-61293050 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550703086 | chr5:61293053-61293054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs138131284 | chr5:61293066-61293067 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs539463071 | chr5:61293081-61293082 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs577205961 | chr5:61293170-61293171 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553668685 | chr5:61293193-61293194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs142639781 | chr5:61293202-61293203 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs538512465 | chr5:61293203-61293204 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs191212271 | chr5:61293210-61293211 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs556632897 | chr5:61293246-61293247 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182374869 | chr5:61293282-61293283 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34897748 | chr5:61293287-61293288 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs114262754 | chr5:61293369-61293370 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs369770487 | chr5:61293407-61293408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577579279 | chr5:61293418-61293419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144056896 | chr5:61293557-61293558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs560311322 | chr5:61293596-61293597 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs528383957 | chr5:61293641-61293642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs548228266 | chr5:61293642-61293643 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs561878909 | chr5:61293643-61293644 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs530727951 | chr5:61293653-61293654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs574968680 | chr5:61293908-61293909 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs564225613 | chr5:61293929-61293930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs541977687 | chr5:61293937-61293938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs79077833 | chr5:61293943-61293944 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs201741864 | chr5:61293951-61293952 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs368308738 | chr5:61293952-61293953 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs570579310 | chr5:61293962-61293963 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs148863258 | chr5:61293976-61293977 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13175940 | chr5:61293994-61293995 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs77702068 | chr5:61294067-61294068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186813652 | chr5:61294108-61294109 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs189674638 | chr5:61294122-61294123 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs542488607 | chr5:61294131-61294132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs370091068 | chr5:61294228-61294229 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555796709 | chr5:61294236-61294237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs575748403 | chr5:61294244-61294245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs538062209 | chr5:61294265-61294266 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557960592 | chr5:61294303-61294304 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374549914 | chr5:61294321-61294322 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs13180268 | chr5:61294425-61294426 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs540374206 | chr5:61294454-61294455 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs554127250 | chr5:61294471-61294472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs561125342 | chr5:61294483-61294484 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs376230245 | chr5:61294495-61294496 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:61286600-61293400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr5:61288000-61294800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr5:61291200-61293200 | Enhancers | Fetal Intestine Large | intestine |
4 | chr5:61291800-61293400 | Enhancers | Fetal Intestine Small | intestine |
5 | chr5:61292600-61295400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr5:61293200-61294200 | Weak transcription | Fetal Intestine Large | intestine |
7 | chr5:61293400-61294600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr5:61293400-61296200 | Weak transcription | Fetal Intestine Small | intestine |
9 | chr5:61294200-61294800 | Enhancers | Fetal Intestine Large | intestine |